Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. uri icon

authors

  • Dodda, Balasunder R
  • Cline, J Mark
  • Witt-Enderby, Paula A
  • Davis, Vicki L
  • Bondi, Corry D
  • Hasan, Mahmud
  • Clafshenkel, William P
  • Gallagher, Katie M
  • Kotlarczyk, Mary P
  • Sethi, Shalini
  • Buszko, Ethan
  • Latimer, Jean J

publication date

  • July 9, 2019